Oral mucositis is a side effect of radiation therapy to the head and neck. Symptoms of oral mucositis include dry mouth, thick saliva, mouth ulcers, bleeding, difficulty swallowing, talking, eating, ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The ...

Oropharyngeal mucositis is an acute and distressing toxic effect of chemotherapy and head and neck irradiation. This oral sequela significantly impairs the daily functioning and quality of life of ...

More than 80% of patients with head and neck cancer develop painful oral mucositis during radiation treatment. Researchers from the Mayo Clinic and other institutions compared two topical therapies ...

MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX”) (TSX-V: MDX) announces it will initiate a targeted marketing campaign following an announcement by a worldwide coalition of ...

Biopharmaceutical company Soligenix has completed enrollment of additional subjects in the phase II study for its SGX942 oral mucositis treatment. SGX942 is an "innate defense regulator," according to ...

Green tea shines as a natural powerhouse of antioxidants, with catechins leading the charge among its polyphenols, which protect cells from oxidative stress. These powerful compounds neutralize ...

Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims Mucositis is the clinical term for damage done to the mucosa by anticancer therapies. It can occur ...

For tens of thousands of Australians who receive radiotherapy as part of their cancer treatment, mucositis is a serious side effect that may cause inflammation, ulcers, diarrhea, nausea and vomiting, ...

The Food and Drug Administration agreed to speed up the review of avasopasem to treat severe oral mucositis in patients with head and neck cancer. The Food and Drug Administration (FDA) granted a ...

The stock of small-cap biotech Jaguar Health Inc. rose 3% on Wednesday, after the company launched its gelclair treatment for oral mucositis, a common side effect suffered by head and neck cancer ...

Whether or not the model proposed by Sonis is correct remains to be elucidated, but it provides a biological basis for testing mucositis intervention. In the past 10 years, more than 25 prophylactic ...